Anti-Hemophilic Factor VIII Concentrate
A lyophilized concentrate of coagulation Factor VIII derived from human plasma, used therapeutically for hemophilia A treatment. Classified under HTS 3002.90.52 as an other blood fraction prepared for therapeutic uses via biotechnological purification. It replaces missing clotting factors in patients.
Import Duty Rates by Country of Origin
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If classified as a specific immunological product like a growth factor
Certain biotech-modified peptides may shift to immunological products subheading if not purely blood fractions.
If put up in measured doses for retail sale
Medicaments in dosage form, even if blood-derived, may classify under Chapter 30 headings 3003/3004.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right HTS code — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Include lot-specific release certificates from FDA or equivalent for biologics import clearance
• Maintain ultra-low temperature shipping records (-80°C) to preserve potency during transit
• Beware of quota restrictions on plasma products; verify annual allocations with Customs
Related Products under HTS 3002.90.52
Human Serum Albumin 20% Solution
A sterile solution of human serum albumin at 20% concentration, prepared from human plasma for therapeutic use in treating hypovolemia and shock. It falls under HTS 3002.90.52 as a blood fraction prepared for therapeutic uses. This product is biotechnologically processed to ensure purity and safety.
IVIG Intravenous Immunoglobulin
A pooled immunoglobulin G preparation from human plasma for intravenous administration in immunodeficiency disorders. HTS 3002.90.52 covers it as other blood fractions prepared for therapeutic uses. Biotechnological processes ensure high purity and immune modulation.
Cryoprecipitated Antihemophilic Factor
Cryoprecipitate from fresh frozen plasma containing Factor VIII, fibrinogen, and von Willebrand factor for therapeutic clotting support. Under HTS 3002.90.52 as other animal/human blood products prepared for therapeutic uses. Commonly used in surgical bleeding management.
Monoclonal Antibody Infusion for Cancer Therapy
Biotechnologically produced monoclonal antibodies like rituximab for therapeutic infusion in lymphoma treatment. HTS 3002.90.52 includes such immunological products prepared for therapeutic uses. They target specific cancer cells via immune regulation.
Botulism Antitoxin Serum
Equine-derived antiserum containing antibodies against botulinum toxin for therapeutic treatment of botulism poisoning. Classified in HTS 3002.90.52 as other antisera prepared for therapeutic uses. Essential for emergency prophylactic administration.
Rh Immune Globulin Injection
Human anti-D immunoglobulin for prophylactic prevention of Rh hemolytic disease in newborns. HTS 3002.90.52 as other blood fractions and immunological products for prophylactic uses. Administered to Rh-negative mothers post-delivery.